TOI ONCOLOGY INSTITUTE INC (THE)

The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos

The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos

CERRITOS, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, today announced the launch of its Lung Cancer Center of Excellence in Fort Lauderdale, Florida. The new center will be led by world-renowned thoracic oncologist Dr. Edgardo S. Santos Castillero, whose career has been defined by groundbreaking research, clinical excellence, and a deep commitment to patient care.

The Lung Cancer Center of Excellence provides patients across Florida with access to advanced treatments including clinical trials, delivered in a compassionate, community-based setting. By combining global expertise with local access, TOI delivers world-class cancer care and the personal connection of community oncology.

“Lung cancer remains one of the leading causes of cancer-related deaths, and patients deserve access to the latest therapies and expert care without the burden of traveling long distances,” said Dr. Santos. “At the Lung Cancer Center of Excellence, we bring advanced diagnostics, innovative treatments, and a whole-patient approach to South Florida so patients and their families can focus on healing.”

Dr. Santos, who has held leadership roles at Tulane University, the University of Miami/Sylvester Comprehensive Cancer Center, and the Lynn Cancer Institute, is internationally recognized as one of the foremost authorities in thoracic oncology. He has published extensively in peer-reviewed journals, serves on leadership committees for national and international oncology organizations, and is a sought-after speaker at oncology conferences worldwide.

“Our vision is to redefine lung cancer care by combining the most advanced value-based therapies with personalized, compassionate treatment,” said Daniel J. Virnich, Chief Executive Officer of The Oncology Institute. “The Lung Cancer Center of Excellence reflects TOI’s mission to expand access to high-quality cancer care across diverse communities, and improve clinical outcomes while lowering financial toxicity for patients and payor partners.”

About The Oncology Institute ():

Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.

Media

The Oncology Institute, Inc.





Investors

ICR Healthcare



EN
02/09/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ONCOLOGY INSTITUTE INC (THE)

 PRESS RELEASE

The Oncology Institute Launches Lung Cancer Center of Excellence in Fl...

The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos CERRITOS, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, today announced the launch of its Lung Cancer Center of Excellence in Fort Lauderdale, Florida. The new center will be led by world-renowned thoracic oncologist Dr. Edgardo S. Santos Castillero, whose career has been defined by groundbreaking research, clinical excellence, and a deep commitment to patient c...

 PRESS RELEASE

The Oncology Institute and Doctors Healthcare Plans Partner to Elevate...

The Oncology Institute and Doctors Healthcare Plans Partner to Elevate Oncology Care Management in South Florida CERRITOS, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a national leader in value-based oncology care, is pleased to announce a strategic partnership with Doctors HealthCare Plans, a Medicare Advantage plan serving members across South Florida. The Oncology Institute will provide delegated utilization management services and clinical advisory support, helping Doctors HealthCare Plans ensure high-quality, cost-effective c...

 PRESS RELEASE

The Oncology Institute Reports Second Quarter 2025 Financial Results a...

The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance CERRITOS, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended June 30, 2025. Daniel Virnich, CEO of TOI, commented, "We delivered another strong quarter with over 20% year-over-year revenue growth. This was driven by exceptional performance in our pharmacy business, which grew over 40% ...

 PRESS RELEASE

The Oncology Institute Announces Changes to Board of Directors

The Oncology Institute Announces Changes to Board of Directors Richard Barasch to Retire; Anne McGeorge Brings Extensive Financial Experience to Role as New Chairman CERRITOS, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Richard Barasch will retire from his role as Chairman of the Board, effective August 12, 2025. Anne McGeorge, who currently serves as a Board Member and Chair of the Audit Committee, will succeed Barasch in the role. “We are thrille...

 PRESS RELEASE

The Oncology Institute Announces Second Quarter 2025 Earnings Release ...

The Oncology Institute Announces Second Quarter 2025 Earnings Release Date and Conference Call CERRITOS, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that the company will release its second quarter 2025 financial results after the market close on Wednesday, August 13, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international cal...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch